Therapeutics that target lipids called ceramides might hold potential for treating cardiometabolic disease, argues a review article published November 5th in the journal Trends in Pharmacological Sciences....
Getting poked in the eye with a sharp object is a cringeworthy thought. However, many patients with posterior eye diseases — back of the eye diseases such as macular degeneration or diabetic retinopathy...
The COVID-19 pandemic has prompted considerable investigation into how the SARS-CoV-2 Spike protein attaches to a human cell during the infection process, as this knowledge is useful in designing vaccines...
While rare, botulism can cause paralysis and is potentially fatal. It is caused by nerve-damaging toxins produced by Clostridium botulinum—the most potent toxins known. These toxins are often found...
WHO warns of surge in coronavirus cases in Europe
EEurope is seeing more weekly coronavirus cases than it did in March’s peak; Amy Kellogg reports.
Editors of a highly respected medical journal discussed...
While some of the more obvious barriers to digital therapeutics adoption in Europe have come crashing down recently, adoption is still hampered by cultural momentum. That was the conclusion of a group...
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok